LIMINATUS PHARMA, INC. (LIMNW) Operating cash flow 2024–2025
LIMINATUS PHARMA, INC. (LIMNW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.0MFY2025 · since FY2024: -$1.5M → -$10.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.0M | -586.6% |
| FY2024 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice